Philip Morris Seeks FDA MRTP Label, Claims ZYN Cuts Six Disease Risks
PM presented scientific findings to the FDA’s Tobacco Products Scientific Advisory Committee supporting its MRTP application for ZYN nicotine pouches, asserting that switching reduces risks of six major smoking-linked diseases. FDA materials deemed the proposed reduced-risk claim scientifically accurate, paving the way for adult-smoker marketing.
1. Company Reduces Stake in Philip Morris International
First Citizens Bank & Trust Co. trimmed its position in Philip Morris International by 12.3% during the third quarter, according to its latest Form 13F filing with the SEC. The bank sold 6,120 shares, reducing its total holdings to 43,799 shares. As of the end of the quarter, this position carried a reported value of $7.104 million. This strategic reallocation marks one of the larger single-fund reductions among financial institutions in the tobacco sector during the period.
2. Institutional Ownership and Activity Trends
Philip Morris International remains heavily held by institutions, which collectively own 78.63% of outstanding shares. In the second quarter, Legacy Investment Solutions LLC and Traub Capital Management LLC each established new positions worth approximately $25,000. Marquette Asset Management LLC dramatically expanded its stake by 1,677.8%, adding 151 shares to reach a total of 160 shares valued at $26,000. Briaud Financial Planning Inc. increased its holdings by 266.7%, acquiring an additional 120 shares for a total position valued at $30,000. Estabrook Capital Management also initiated a new stake worth $30,000 during the same period.
3. Recent Dividend and Payout Profile
Philip Morris International declared a quarterly dividend with a payment on January 14th to shareholders of record as of December 26th. The dividend translates to an annualized payout of $5.88 and represents a yield of 3.4%. With a payout ratio exceeding 100%—at 106.5%—the dividend policy underscores the company’s commitment to shareholder returns, while raising questions about long-term sustainability amid shifting industry dynamics.
4. Analyst Ratings and Consensus Targets
Eleven equity analysts currently maintain a Buy rating on Philip Morris International shares, while two have assigned a Hold rating. The collective average price target stands at 184.56, reflecting a Moderate Buy consensus. Notable recent reports include Morgan Stanley’s Overweight recommendation, Goldman Sachs’ reiterated Buy rating, and Barclays’ Overweight stance with a target adjustment to 180.00. Wall Street Zen downgraded its outlook to Hold at the start of the year, illustrating diverging views on the company’s growth trajectory and exposure to regulatory risks.